How Wegovy and Mounjaro Doses Actually Compare
Understanding Wegovy Mounjaro Equivalent Doses for Prescription Weight Loss
When comparing wegovy mounjaro equivalent doses, it's essential to understand that these aren't directly interchangeable medications with simple 1:1 dose conversions. Wegovy contains semaglutide, a GLP-1 receptor agonist, whilst Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist—fundamentally different mechanisms requiring distinct dosing approaches. Your prescriber evaluates your individual response, medical history, and weight loss goals rather than applying mathematical equivalency formulas.
The prescription weight loss journey with either medication follows carefully structured dose escalation schedules designed to minimise side effects whilst maximising therapeutic benefit. Wegovy progresses through five doses (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg) over 16 weeks, whilst Mounjaro follows its own four-dose pathway (2.5mg, 5mg, 10mg, 15mg) over 12 weeks. Both treatments require clinical assessment and ongoing monitoring through our GPhC-registered pharmacy service (#9012878) to ensure optimal outcomes for your weight management goals.
Wegovy Mounjaro Equivalent Doses: Pricing and Value Comparison
EverydayMeds offers transparent pricing for both prescription weight loss options, with Wegovy single pens starting at £79.99 (0.25mg starter dose) after applying code FIRST40 for new customers. Our pricing structure reflects the different dose escalation schedules, with Wegovy progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 (2.4mg maintenance dose). Returning customers benefit from code DOSE25 applied at checkout, making ongoing treatment accessible and predictable.
Understanding wegovy mounjaro equivalent doses extends beyond cost comparison to treatment value and convenience factors. Our Intro Duo bundle (0.25mg & 0.5mg Wegovy) costs £169.99, providing your first 8 weeks of treatment with Reliable Supply continuity. The Ultimate Stability Trio offers three months of maintenance 2.4mg doses for £649.99, eliminating the need for multiple orders. Both treatments are available through the same streamlined process, with your prescriber recommending the most suitable option based on clinical rather than cost considerations.
Clinical Evidence Behind Wegovy Mounjaro Equivalent Doses
The STEP clinical trial programme demonstrates Wegovy's efficacy in prescription weight loss, with participants achieving approximately 15% average weight reduction at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). These results represent outcomes in controlled clinical settings and individual responses may vary significantly based on adherence, lifestyle factors, and metabolic differences.
When considering wegovy mounjaro equivalent doses, both medications showed substantial weight loss in their respective clinical programmes, though direct head-to-head comparisons weren't conducted due to different trial designs and patient populations. The SELECT cardiovascular outcomes trial further demonstrated Wegovy's potential in reducing major cardiovascular events by 20%, adding clinical value beyond weight management for eligible patients with existing cardiovascular risk factors.
How Wegovy Works in Prescription Weight Loss Treatment
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of incretin hormones naturally produced in your intestine following meals. This mechanism reduces appetite by acting on brain centres responsible for hunger and satiety, helping you feel fuller after smaller portions and potentially reducing food cravings between meals. The once-weekly injection provides consistent therapeutic levels, supporting sustainable eating pattern changes rather than requiring daily medication management. Understanding this mechanism helps clarify why wegovy mounjaro equivalent doses aren't simply interchangeable—each medication targets different receptor pathways with distinct physiological effects. The prescription-only medicine works most effectively alongside a reduced-calorie diet and increased physical activity, creating a comprehensive approach to long-term weight management.
Ordering Process for Wegovy Mounjaro Equivalent Doses
EverydayMeds streamlines access to both prescription weight loss treatments through our 3-minute online clinical assessment, eliminating traditional GP appointment delays whilst maintaining clinical safety standards. Our qualified prescribers review your medical history, current medications, and weight loss goals within standard 3 working days (express 24-hour review available), determining which treatment and starting dose best suits your individual circumstances. Once approved, next-day delivery ensures prompt treatment commencement through our temperature-controlled cold-chain logistics, maintaining medication efficacy from our GPhC-registered pharmacy (#9012878) to your door. The process includes comprehensive patient information leaflets, injection training resources, and ongoing clinical support throughout your weight management journey. Both Wegovy and Mounjaro follow identical ordering procedures, with your prescriber's recommendation determining the most appropriate option rather than patient preference alone.
Storage and Practical Considerations for Wegovy Mounjaro Equivalent Doses
Wegovy offers practical advantages in storage flexibility, remaining stable at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require initial refrigerated storage at 2-8°C and utilise pre-filled FlexTouch pen devices for convenient once-weekly injection. The dose escalation schedules differ significantly—Wegovy's 16-week titration period allows more gradual physiological adaptation compared to Mounjaro's 12-week schedule, potentially affecting tolerability in sensitive patients. Understanding these practical differences helps inform treatment choice beyond simple wegovy mounjaro equivalent doses comparison. Regular injection site rotation and proper disposal of used pens through household waste (with needle safety cap) ensures safe ongoing treatment management.
Individualised Dose Selection Beyond Wegovy Mounjaro Equivalent Doses
Prescription weight loss treatment success depends on personalised dose selection rather than generic equivalency calculations between different medications. Your prescriber considers factors including baseline BMI, diabetes status, cardiovascular risk profile, previous weight loss treatment responses, and concurrent medications when determining optimal starting doses and escalation schedules. The concept of wegovy mounjaro equivalent doses oversimplifies these complex clinical decisions that require individual assessment and ongoing monitoring.
EverydayMeds' clinical team recognises that effective weight management extends beyond medication selection to comprehensive lifestyle support and realistic expectation setting. Both treatments require commitment to dietary changes and increased physical activity for optimal outcomes, with medication serving as a tool to support these fundamental lifestyle modifications. Our prescribers provide ongoing guidance on dose adjustments, side effect management, and treatment duration decisions based on individual progress and clinical response rather than predetermined protocols.
Accessing Wegovy Through EverydayMeds
Both Wegovy and Mounjaro remain available through EverydayMeds with identical clinical assessment and prescription processes, ensuring access to whichever treatment your prescriber recommends as most suitable. New customers benefit from code FIRST40 applied at checkout, whilst returning customers use code DOSE25 for continued savings throughout their weight management journey. Our comprehensive service includes clinical review, next-day delivery, ongoing prescription management, and access to clinical support when needed throughout your treatment. The streamlined process eliminates traditional healthcare delays whilst maintaining rigorous safety standards through qualified prescriber oversight and GPhC-registered pharmacy dispensing. Rather than focusing on wegovy mounjaro equivalent doses, our approach prioritises clinical appropriateness and individual treatment optimisation for sustainable weight loss outcomes.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
